Novartis’ biotech subsidiary AveXis has added 350 employees to support the development of the gene therapy Zolgensma, for spinal muscular atrophy. AveXis acquired the 700,000-square-foot, six-building campus in Longmont, in April of last year. Yourway has strategic depots located around the world to support the shipment of cell and gene therapies.